Affini-T
Affini-T Therapeutics is a biotechnology company developing T-cell therapies for patients suffering from cancer.
$175M Series A ·
Source: fundraisingfox.com
Funding history ↓Signals
X account@affinit_tx · created Aug 2, 2021 (5 years old) · 243 followers
Website registeredAug 25, 2020 (6 years old)
TIMELINE · MONEY RAISED
Affini-T | 574 days from website to first raise on record
Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series A | $175M | — | fundraisingfox.com |
Timeline
- X account created
- Website created
Founders and team
AG
Arjun Goyal FounderJK
Jak Knowles FounderKY
Kathy Yi Chief Operating OfficerKN
Kim Nguyen Chief Technical OfficerLV
Loic Vincent CSO
Investors
AAgent Capital
AAlexandria Venture Investments
CCatalio
- EErasca Ventures
FFred Hutchinson
HHumboldt Fund
JJacket River
LLeaps by Bayer
PParker Institute for Cancer Immunotherapy
VVida Ventures
Companies like Affini-T
PPushCART TherapeuticsSeed · Jul 2026
SSwarm OncologySeed · Mar 2026
SStorm Therapeutics$56M Series B+ · Apr 2026
WWugen$35M Series B+ · Jul 2026CCartography Biosciences$67M Series B+ · Oct 2025
TTriumvira Immunologics$45M Series A · Mar 2022
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/affini-t (get a free API key).